Virtual Patient Care is a free online service where patients can speak with experienced registered nurses and get personalized answers to their questions.
In this video by Michael Wong, Founder and Executive Director of the Physician-Patient Alliance for Health & Safety explains what prompted the Physician-Patient Alliance and its cardiovascular partners – American Heart Association, AC Forum, Heart Rhythm Society, StopAfib.org, Mended Hearts, and Preventive Cardiovascular Nurses Association – to establish a nursing chat line:
“During the current COVID-19 conditions, patients face the burdens of social distancing and increased difficulty in reaching clinicians busy with emergencies. To meet the pressing needs of patients during this COVID pandemic, the Physician-Patient Alliance, with an unrestricted grant from the BMS-Pfizer Alliance, and our cardiovascular partners recently launched a free virtual patient care website and chat line.”
Editor’s note: Blood clots are occurring in patients diagnosed with COVID-19. This article offers some of the key treatments and recommendations you may experience when admitted to hospital and then discharged home. As well, it discusses the interim clinical guidance from the Anticoagulation Forum.
By Michael Wong (Founder/Executive Director, Physician-Patient Alliance for Health & Safety)
An average of 274 people die from blood clots – which works out to about one death every six minutes. These statistics are pre-COVID statistics.
Because of the current COVID-19 pandemic, this may be changing. There have been reports about the development of venous thromboembolism (VTE) in patients with COVID-19. The International Society on Thrombosis and Haemostasis has collected a number of studies and case reports on thrombosis in COVID-19 patients, and the Journal of American College of Cardiology released a review of current understanding, citing many of the studies and case reports which are on the ISTH site.
This COVID-19 pandemic is proving a challenge for clinicians to care for patients diagnosed with COVID-19. The interim clinical guidance from the Anticoagulation Forum (AC Interim Guidance) discusses the challenges of diagnosing a thrombotic event in COVID patients:
Editor’s note: Our understanding of COVID-19 symptomatology is evolving as the current pandemic unfolds. The International Society on Thrombosis and Haemostasis has collected a number of studies and case reports on thrombosis in COVID-19 patients. The Journal of American College of Cardiology released a review of current understanding, citing many of the studies and case reports which are on the ISTH site. This COVID-19 pandemic challenges us to use current knowledge and innovate new approaches to care for patients diagnosed with COVID-19. This article seeks to summarize some of the current knowledge about thrombosis in COVID-19 patients, knowing that future studies and case reports will undoubtedly refine the statements made below. However, this is science, continually evolving and improving based on current understanding. With that, this article offers some insights about VTE in patients admitted to the hospital who have been diagnosed with COVID-19.
By Michael Wong (Founder/Executive Director, Physician-Patient Alliance for Health & Safety), Laurie Paletz, BSN PHN RN BC SCRN (Manager, Stroke Program Department of Neurology, Cedars-Sinai), and Thereza B. Ayad, RN, MSN, DNP, CNOR (Assistant Professor, University of Massachusetts Medical School-Graduate School of Nursing; Surgical Services Clinical Staff Educator, North Shore Medical Center)
(reviewed by Sue Koob, MPA, Chief Executive Officer, Preventive Cardiovascular Nurses Association and Pat Salber, MD, MBA, Editor-in-Chief, DoctorWeighsIn)
If you have questions, the Physician-Patient Alliance for Health & Safety launched a free online service (the CV Virtual Clinic) where patients can speak with experienced registered nurses and get personalized answers to their questions.
The Physician-Patient Alliance for Health and Safety (PPAHS) today announced the launch of a new, free virtual clinic and website, Virtual Patient Care, in response to the COVID-19 crisis, to meet the pressing needs of patients with atrial fibrillation (Afib), who are at the highest level of risk from stroke, and to help Afib patients cope with the difficulties imposed by COVID-19.
“Under current COVID-19 conditions, patients face the burdens of social distancing and increased difficulty in reaching clinicians busy with emergencies. Telehealth has proven essential in addressing patients’ pressing health needs and ensuring good patient-to-clinician dialogue,” said Michael Wong, JD, Founder and Executive Director of the Physician-Patient Alliance for Health & Safety. “With today’s launch of Virtual Patient Care and the CV Virtual Clinic, vital telehealth benefits are now also extended to Afib patients in need.”
You may have never heard of amniotic fluid embolism (AFE), but if you are pregnant or know someone who is, AFE is a condition that you may want to learn more about. Little has been written or researched about AFE, so you might want to refer to these articles to learn more.
In celebration of World Thrombosis Day 2019, here are four much-watch videos on the need to assess all maternal patients for the risk of VTE and to provide the recommended prophylaxis treatment, depending on whether the mother is antepartum or postpartum.
Blood Clots Are Preventable in Pregnant Mothers
Blood clots are preventable in pregnant mothers, but to make this happen, all maternal patients need to be assessed for the risk of DVT and, if the patient is found to be at risk, the patient must be provided the recommended prophylactic treatments. In this video, Michael Wong, JD (Founder and Executive Director) discusses PPAHS put together an expert panel to develop the OB VTE Safety Recommendations. He encourages all maternal patients to be assessed and treated for VTE.
Editor’s note: In this editorial from the desk of PPAHS’s Executive Director, to help prevent blood clots PPAHS says that clinicians and their patients need to know who is at risk and be knowledgeable about the alternatives.
By Michael Wong, JD (Founder/Executive Director, Physician-Patient Alliance for Health & Safety)
Birth Control Pills and Blood Clots
Two women – one in the United States and one in Ireland – both recently experienced near-death experiences. Despite being separated by the Atlantic Ocean, both share a widespread practice – they both were taking birth control pills. According to a survey by the CDC, 62% of women of reproductive age are currently using contraception.
In the United States, WREG 3 News reports that 18-year-old Hailey Duncan from Memphis, Tennessee “was rushed to Baptist after she suffered a pulmonary embolism likely caused by birth control pills that blocked off most of the blood flow to her lungs. She went into cardiac arrest several times on the way to the hospital.”
In this article, Niran S. Al-Agba, MD (Mom, pediatrician, and Associate Editor at The Deductible); Michael Wong, JD (Executive Director, Physician-Patient Alliance for Health & Safety) and John Bianchi (Vice President, Finn Partners) discuss the maternal morbidity and mortality epidemic in the US. Seeking to stem this epidemic, The Preventing Maternal Deaths Act was recently signed into law.
Now, the question is how to reduce the national crisis of maternal morbidity and mortality. To reverse increasing maternal mortality, prioritizing venous thromboembolism — the leading medical cause of maternal death in pregnancy — will help lower maternal morbidity and mortality.
PPAHS is proud to support and participate in WomenHeart’s National AFib Month Screening Campaign. PPAHS asks clinicians to please screen for AFib.
By WomenHeart (WomenHeart: The National Coalition for Women with Heart Disease, is a nonprofit, 501(c)(3) patient advocacy organization with thousands of members nationwide, including women heart patients and their families, health care providers, advocates and consumers committed to helping women live longer, healthier lives. WomenHeart supports, educates and advocates on behalf of the nearly 48 million American women living with or at risk of heart disease.)
Approximately 1.5 million American women live with atrial fibrillation (AFib), which is an irregular heartbeat. One of the most effective means of detection of AFib is through “opportunistic screenings” with primary care providers, these screenings identify more people with AFib than arranged screenings.